Clinical Trials: Hyperparathyroidism

Birmingham : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Birmingham : Site Ref # / Investigator 37082

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Phoenix : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Tempe : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Los Angeles : Site Reference ID/Investigator# 55342 Updated

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

Los Angeles : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Los Angeles : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

San Francisco : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

San Francisco : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Gainesville : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gainesville : Site Ref # / Investigator 26762

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Orlando : Site Ref # / Investigator 28529

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Atlanta : Site Ref # / Investigator 26748

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Atlanta : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Chicago : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

New Orleans : Site Ref # / Investigator 37582

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Baltimore : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Baltimore : Site Ref # / Investigator 39973

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Boston : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Boston : Site Ref # / Investigator 26769

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Springfield : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Detroit : Site Ref # / Investigator 26768

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Royal Oak : William Beaumont Health Center

Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery

Kansas City : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Kansas City : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Kansas City : Site Ref # / Investigator 26747

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

St. Louis : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Livingston : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Bronx : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

New York : Columbia University Medical Center

Denosumab in Primary Hyperparathyroidism

Durham : Duke University Medical Center Dialysis Unit

How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis

Greenville : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Akron : Site Ref # / Investigator 26749

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Cincinnati : Site Ref # / Investigator 26751

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Columbus : Site Ref # / Investigator 26765

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Oklahoma City : Site Ref # / Investigator 28528

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Portland : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Portland : Site Ref # / Investigator 26763

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Bethlehem : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Philadelphia : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Nashville : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Dallas : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Houston : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

San Antonio : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Salt Lake City : Site Reference ID/Investigator# 48566 Updated

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis

Charlottesville : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Charlottesville : Site Ref # / Investigator 28526

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Seattle : Site Ref # / Investigator 26758

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Madison : Site Ref # / Investigator 40382

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Wauwatosa : Site Ref # / Investigator 26759

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Herston : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Parkville : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Westmead : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Vienna : Site Reference ID/Investigator# 53507

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Vienna : Site Ref # / Investigator 53508

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Wien : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Brussels : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Bruxelles : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Edegem : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gent : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gent : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

View More »

Gent : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Leuven : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Leuven : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Leuven : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

London : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Ottawa : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Toronto : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Vancouver : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Beroun : Site Reference ID/Investigator# 45487

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Beroun : Site Reference ID/Investigator# 43449

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Brno : Site Ref # / Investigator 47690

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Brno : Site Reference ID/Investigator# 46744

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Budejovice : Site Ref # / Investigator 46742

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

View More »

Frydek-Mistek : Site Ref # / Investigator 49542

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Karlovy Vary : Site Ref # / Investigator 51003

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Marianske Lazne : Site Ref # / Investigator 51004

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Novy Jicin : Site Ref # / Investigator 43522

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Novy Jicin : Site Ref # / Investigator 43524

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Novy Jicin : Site Ref # / Investigator 43523

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Ostrava : Site Reference ID/Investigator# 43453

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Pardubice : Site Ref # / Investigator 51007

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Plzen : Site Reference ID/Investigator# 46743

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Prague 10 : Site Ref # / Investigator 51008

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Prague 9 : Site Ref # / Investigator 51011

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Slany : Site Ref # / Investigator 51012

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Trutnov : Site Reference ID/Investigator# 43448

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bordeaux Cedex : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Montpellier cedex 05 : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Aachen : Site Reference ID/Investigator# 28352

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Alsfeld : Site Reference ID/Investigator# 28359

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Arnstadt : Site Reference ID/Investigator# 28305

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Aschersleben : Site Reference ID/Investigator# 28306

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Augsburg : Site Reference ID/Investigator# 28003

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

View More »

Bad Bevensen : Site Reference ID/Investigator# 28017

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Bad Nenndorf : Site Reference ID/Investigator# 28301

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Balingen : Site Reference ID/Investigator# 28296

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Berlin : Site Reference ID/Investigator# 28303

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Berlin : Site Ref # / Investigator 54050

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Berlin : Site Reference ID/Investigator# 28021

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Berlin : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Bernburg : Site Reference ID/Investigator# 28022

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Betzdorf : Site Reference ID/Investigator# 30862

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Bielefeld : Site Reference ID/Investigator# 28007

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Burg : Site Reference ID/Investigator# 28304

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Coburg : Site Reference ID/Investigator# 28014

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Cottbus : Site Reference ID/Investigator# 28023

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Demmin : Site Reference ID/Investigator# 28134

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Dresden : Site Reference ID/Investigator# 43903

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Elsenfeld : Site Reference ID/Investigator# 28284

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Erfurt : Site Reference ID/Investigator# 48864

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Erkelenz : Site Ref # / Investigator 72343

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Eschweiler : Site Reference ID/Investigator# 28029

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Friedrichroda : Site Reference ID/Investigator# 28287

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Gera : Site Reference ID/Investigator# 28276

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Halle : Site Reference ID/Investigator# 28351

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hamburg : Site Ref # / Investigator 28280

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hannover : Site Reference ID/Investigator# 48865

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hannover : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Heidelberg : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Heilbronn : Site Reference ID/Investigator# 28300

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Herford : Site Reference ID/Investigator# 28011

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Herzberg : Site Reference ID/Investigator# 28019

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hildesheim : Site Reference ID/Investigator# 28135

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Hoyerswerda : Site Reference ID/Investigator# 28286

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Ilfeld : Site Reference ID/Investigator# 28353

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Jena : Site Reference ID/Investigator# 28044

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Kiel : Site Reference ID/Investigator# 48863

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Kiel : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Lahr : Site Reference ID/Investigator# 28013

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Loerrach : Site Reference ID/Investigator# 28025

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Ludwigslust : Site Reference ID/Investigator# 28290

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Magdeburg : Site Reference ID/Investigator# 10982

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Malente : Site Reference ID/Investigator# 28291

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Mannheim : Site Reference ID/Investigator# 28036

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Marburg : Site Reference ID/Investigator# 28302

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Mullheim : Site Reference ID/Investigator# 28278

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Nordhorn : Site Reference ID/Investigator# 28275

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Oberstdorf : Site Reference ID/Investigator# 43904

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Osnabrueck : Site Reference ID/Investigator# 28277

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Peine : Site Reference ID/Investigator# 28297

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Pirmasens : Site Reference ID/Investigator# 28307

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Potsdam : Site Reference ID/Investigator# 28295

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Quedlinburg : Site Reference ID/Investigator# 28294

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Rendsburg : Site Reference ID/Investigator# 48862

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Ribnitz-Damgarten : Site Reference ID/Investigator# 28042

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Rostock : Site Reference ID/Investigator# 28282

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

St. Wendel : Site Reference ID/Investigator# 28033

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Stuttgart : Site Reference ID/Investigator# 28005

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Stuttgart : Site Ref # / Investigator 54052

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Viersen : Site Reference ID/Investigator# 28020

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Villingen-Schwenningen : Site Reference ID/Investigator# 28293

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Voelklingen : Site Reference ID/Investigator# 28018

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Weissenfels : Site Reference ID/Investigator# 28298

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Wetzlar : Site Reference ID/Investigator# 28292

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Wiesbaden : Site Reference ID/Investigator# 48882

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Wolfenbuettel : Site Reference ID/Investigator# 28299

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Zwickau : Site Reference ID/Investigator# 28279

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients With Paricalcitol in German and Austrian Clinical Practice

Arta : Site Ref # / Investigator 56803

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Athens : Site Ref # / Investigator 53424

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Larissa : Site Ref # / Investigator 53425

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Lefkada : Site Ref # / Investigator 56805

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Patras : Site Ref # / Investigator 56809

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

View More »

Patras : Site Ref # / Investigator 66291

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Pylaia : Site Ref # / Investigator 50442

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Volos : Site Ref # / Investigator 53422

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Budapest : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Debrecen : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Pecs : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Szeged : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Jerusalem. : Endocrinology Clinic, Clalit Health Services

Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density

Acquaviva delle Fonti : Ospedale generale regionale "Miulli"

Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism

Genova : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Milano : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Padova : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Sendai :

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Seoul : Seoul National University Hospital

Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level

Aguascalientes : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Mexico : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gdansk : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Gdansk : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Katowice : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Lodz : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Lodz : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

View More »

Poznan : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Szczecin : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Szczecin : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Warszawa : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Bucharest : Site Ref # / Investigator 42877

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42882

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42883

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42975

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42976

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

View More »

Bucharest : Site Ref # / Investigator 42880

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42881

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42963

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42970

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Bucharest : Site Ref # / Investigator 42973

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Cluj-Napoca : Site Ref # / Investigator 42980

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Cluj-Napoca : Site Ref # / Investigator 42981

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Cluj-Napoca : Site Ref # / Investigator 42982

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Cluj-Napoca : Site Ref # / Investigator 63623

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Constanta : Site Ref # / Investigator 43009

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Craiova : Site Reference ID/Investigator# 43006

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Craiova : Site Ref # / Investigator 43002

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Craiova : Site Ref # / Investigator 43003

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Iasi : Site Ref # / Investigator 42989

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Oradea : Site Ref # / Investigator 42999

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Oradea : Site Ref # / Investigator 43000

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Targu Mures : Site Ref # / Investigator 42984

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Targu Mures : Site Ref # / Investigator 42985

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Timisoara : Site Ref # / Investigator 42994

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Timisoara : Site Ref # / Investigator 42995

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Moscow : Site Ref # / Investigator 58356

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

Moscow : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Saint Petersburg : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Samara : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Banska Bystrica : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Bratislava : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Baracaldo : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Baracaldo : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Barcelona : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Barcelona : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Barcelona : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

View More »

L'Hospitalet de Llobregat : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Madrid : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Madrid : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Santander : Hospital Universitario Marquès de Valdecilla

Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism

Valencia : Research Site Updated

Pediatric Chronic Kidney Disease Safety and Efficacy

Kalmar : Site Ref # / Investigator 47723

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Karlstad : Site Ref # / Investigator 41084

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Kristianstad : Site Ref # / Investigator 45190

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Linkoping : Site Ref # / Investigator 41085

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Norrkoping : Site Ref # / Investigator 41087

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

View More »

Orebro : Site Ref # / Investigator 45188

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Skovde : Site Ref # / Investigator 41088

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Stockholm : Site Ref # / Investigator 57782

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Varnamo : Site Ref # / Investigator 41089

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Vasteras : Site Ref # / Investigator 45191

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Bern : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Geneva 14 : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Zurich : Research Site

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Antalya : Site Ref # / Investigator 37822

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Antalya : Site Ref # / Investigator 40677

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Antalya : Site Ref # / Investigator 68286

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Ref # / Investigator 69973

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Ref # / Investigator 40674

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

View More »

Istanbul : Site Ref # / Investigator 40686

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Ref # / Investigator 61585

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Ref # / Investigator 63765

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Ref # / Investigator 63766

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Istanbul : Site Ref # / Investigator 40672

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Karaman : Site Ref # / Investigator 64444

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Konya : Site Ref # / Investigator 48132

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Mersin : Site Ref # / Investigator 68281

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Mersin : Site Ref # / Investigator 69974

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Bristol : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Glasgow : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Leeds : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Manchester : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease

Nottingham : Research Site

Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease